Subclavian Vein catheterization_Seldinger Vs Modified Seldinger (MS)

May 11, 2014 updated by: Hee-Pyoung Park, Seoul National University Hospital

Comparison of Two Needle Insertion Techniques on Success Rate and Complications During Subclavian Venous Catheterization: Seldinger vs. Modified Seldinger Technique

Seldinger technique is a minimally invasive technique in which the practitioner accesses the target vessel with a small bore needle, then dilates to the size required for the catheter. Contrarily, modified Seldinger technique(guiding sheath-over-the-needle technique) use needle that is covered with guiding sheath.

Both technique is widely used in central venous catheterization, however, few researches have been investigated to compare success rate or complications of both methods.

Study Overview

Detailed Description

The major complications of central venous catheterization through subclavian vein, are unintended arterial puncture, pneumothorax, hemothorax, malposition of catheter etc,. We assume that using modified Seldinger technique (MST), guiding sheath is easily slid over the needle, providing stable route into the vessel lumen relatively.

We aimed to compare the Seldinger technique and modified Seldinger technique(MST) on success rate and complications during subclavian central venous catheterization in this prospective, randomized , controlled trials.

Study Type

Interventional

Enrollment (Anticipated)

418

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Hee Pyung Park, MD PhD
  • Phone Number: 82-2-2072-2466
  • Email: hppark@snu.ac.kr

Study Contact Backup

Study Locations

      • Seoul, Korea, Republic of, 110-799
        • Recruiting
        • Seoul National University of Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Eugene Kim, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient scheduled for surgery under genearl anesthesia and subclavian vein central catheterization

Exclusion Criteria:

  • Patient who does not agree to the study
  • Inflammation or infection on catheterization site
  • Contralateral diaphragmatic dysfunction
  • Anatomic anomalies of subclavian artery or vein/clavicle
  • Previous lung surgical history
  • Patient who has ventriculoperitoneal shunt or chemoport on same side
  • Patient who has pneumo/hemothorax or lung parenchymal disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: GroupC
Group C means Control group which use Seldinger technique for subclavian catheterization. The aimed vessel(subclavian vein) is punctured with a sharp hollow needle, syringe is detached and guidewire is advanced through the lumen of the needle, and the needle is removed. After that catheter is passed over the guidewire into the vessel.

The aimed vessel(subclavian vein) is punctured with a sharp hollow needle, syringe is detached and guidewire is advanced through the lumen of the needle, and the needle is removed.

After that catheter is passed over the guidewire into the vessel.

Other Names:
  • thin-wall needle technique
Experimental: Group MS
Group MS means experimental group which use modified Seldinger technique for subclavian catheterization. The aimed vessel is punctured with the needle that is covered with guiding sheath. After vessel is punctured, guiding sheath is instatntly slid over the needle into the vessel. The needle is removed, guidewire is advanced through the sheath, central catheter is placed into the vessel.
The aimed vessel is punctured with the needle that is covered with guiding sheath. After vessel is punctured, guiding sheath is instantly slid over the needle into the vessel. The needle is removed, guidewire is advanced through the sheath, central catheter is placed into the vessel.
Other Names:
  • guiding sheath-over-the-needle technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major complication rate of subclavian catheterization
Time Frame: intraoperative
Compare main complication rates of subclavian catheterization including pnumothorax, hemothorax, arterial puncture, malposition of cathter.
intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
primary success rate of subclavian catheterization
Time Frame: intraoperative
Check the number of attempts of needling, guidewire advance, and catheterization in both groups.
intraoperative
Total insertion time
Time Frame: From skin puctuation until confim the successful catheterization anticipated within 3min
Check the total insertion time from skin puncture to confirm the successful catheterization via venous aspiration though catheter lumen.
From skin puctuation until confim the successful catheterization anticipated within 3min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hee Pyung Park, MD PhD, Professor
  • Principal Investigator: Eugene Kim, MD, Clinical Instuctor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Anticipated)

May 1, 2016

Study Registration Dates

First Submitted

March 16, 2014

First Submitted That Met QC Criteria

March 17, 2014

First Posted (Estimate)

March 18, 2014

Study Record Updates

Last Update Posted (Estimate)

May 13, 2014

Last Update Submitted That Met QC Criteria

May 11, 2014

Last Verified

March 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Neoplasm

Clinical Trials on Seldinger technique

3
Subscribe